Brief: CASI Pharmaceuticals Announces Q1 Revenue Of $5.7 Mln
13/05/2021 13:32
May 13 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2021
FINANCIAL
RESULTS
* Q1 REVENUE $5.7 MILLION
* EVOMELA Q1 2021 REVENUE CONTINUES UPWARD TREND; POISED TO
MEET
GREATER THAN 50% REVENUE GROWTH GUIDANCE IN 2021
* QTRLY LOSS PER SHARE $0.11
Source text for Eikon: ID:nPn7BfVkja
Further company coverage: CASI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary